Compare EARN & KEQU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EARN | KEQU |
|---|---|---|
| Founded | 2012 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.8M | 110.9M |
| IPO Year | 2012 | 1995 |
| Metric | EARN | KEQU |
|---|---|---|
| Price | $4.38 | $36.76 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.38 | N/A |
| AVG Volume (30 Days) | ★ 373.9K | 5.8K |
| Earning Date | 06-16-2026 | 03-11-2026 |
| Dividend Yield | ★ 20.51% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.22 |
| Revenue | N/A | ★ $138,558,000.00 |
| Revenue This Year | $7.69 | N/A |
| Revenue Next Year | $19.57 | N/A |
| P/E Ratio | ★ N/A | $11.30 |
| Revenue Growth | N/A | ★ 7.72 |
| 52 Week Low | $4.27 | $33.27 |
| 52 Week High | $6.06 | $60.89 |
| Indicator | EARN | KEQU |
|---|---|---|
| Relative Strength Index (RSI) | 42.15 | 47.66 |
| Support Level | $4.30 | $35.15 |
| Resistance Level | $4.78 | $41.25 |
| Average True Range (ATR) | 0.08 | 1.09 |
| MACD | 0.01 | 0.11 |
| Stochastic Oscillator | 40.00 | 42.23 |
Ellington Credit Co The Fund is focused on acquiring and actively managing a portfolio of corporate CLOs, mainly mezzanine debt and equity tranches, which are typically collateralized by portfolios consisting mainly of below-investment-grade senior secured loans with a large number of discrete underlying borrowers across various industry sectors. Additionally, the Fund may also invest in CLO loan accumulation facilities, which are entities that acquire corporate loans and other similar corporate credit-related assets in anticipation of ultimately collateralizing a CLO transaction. The company's primary investment objectives are to generate attractive current income and risk-adjusted total returns for shareholders.
Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.